bpc 157 active ingredient BPC-157 Peptide Therapy BPC-157 by S.T.A. Formulations –

doi: 10.1089/thy.2009.0417

Who should not self-inject: Adults with bleeding or clotting disorders, active infection at intended injection sites, a history of severe needle phobia that has not been clinically addressed, or those administering a peptide without a valid prescription should not proceed without direct clinician guidance

Sterile filtration and aseptic processing The formulated solution undergoes microfiltration and sterilisation to remove microorganisms and contaminants

Preclinical data suggests AOD9604 shifts the metabolic balance toward burning fatty acids for energy rather than storing them, with effects observed particularly in visceral adipose tissue

References Kwon Y, et al